Viewing Study NCT00788333


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-31 @ 9:10 PM
Study NCT ID: NCT00788333
Status: COMPLETED
Last Update Posted: 2012-07-13
First Post: 2008-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module